Document is current
Any future updates will be listed below
-
Authors
Hodge, Daryl
Back, David J.
Gibbons, Sara
Khoo, Saye H.
Marzolini, Catia https://orcid.org/0000-0002-2312-7050
-
Funding
Funding for this research was provided by:
Universität Basel
- License Information
-
More Information
Article History
Accepted: 15 February 2021
First Online: 8 April 2021
Declarations
:
: Open Access funding provided by Universität Basel (Universitätsbibliothek Basel).
: Daryl Hodge and Sara Gibbons have no conflicts of interest to declare. David Back and Saye Khoo have received educational grants for the Liverpool drug interaction website () from Frontier, Gilead Sciences, MSD, Janssen, and ViiV Healthcare. Saye Khoo has also received speakers’ honoraria from ViiV Healthcare, Gilead Sciences, and AbbVie; consultancy fees from ViiV Healthcare and Merck; and research funding from Gilead Sciences and ViiV Healthcare. David Back has also received honoraria for speakers’ bureau or advisory boards received from Gilead Sciences, MSD, and ViiV Healthcare. Catia Marzolini has received research funding from Gilead and honoraria for lectures from MSD.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: DH carried out the literature search. DH prepared the figures and tables. DH and CM wrote the manuscript. DJB, SG and SHK critically reviewed the manuscript.
